×
About 23,478 results

ALLMedicine™ Neuroblastoma Center

Research & Reviews  11,465 results

Activated ALK Cooperates with N-Myc via Wnt/β-catenin Signaling to Induce Neuroendocrin...
https://doi.org/10.1158/0008-5472.CAN-20-3351
Cancer Research; Unno K, Chalmers ZR et. al.

Feb 27th, 2021 - Neuroendocrine prostate cancer (NEPC) is an aggressive subtype of prostate cancer with poor prognosis, and there is a critical need for novel therapeutic approaches. NEPC is associated with molecular perturbation of several pathways including ampl...

Silencing of circular RNA circPDE5A suppresses neuroblastoma progression by targeting t...
https://doi.org/10.1080/00207454.2021.1896505
The International Journal of Neuroscience; Chen Y, Lin L et. al.

Feb 26th, 2021 - Objective: Neuroblastoma (NB) is the most common extra-cranial solid tumor in early childhood. Circular RNAs (circRNAs) have been implicated in the development of NB. The purpose of the current study was to explore the molecular action of circRNA ...

ZIF-8 nano confined protein-titanocene complex core-shell MOFs for efficient therapy of...
https://doi.org/10.1016/j.ijbiomac.2021.02.161
International Journal of Biological Macromolecules; Kulkarni S, Pandey A et. al.

Feb 26th, 2021 - In the present study, we have developed the core-shell metal organic framework (MOF) of zinc, wherein titanocene dichloride (TC) loaded lactoferrin (Lf) functioned as a core. The complexation of TC to Lf was studies using molecular dynamics study,...

Review of the cytological features of olfactory neuroblastoma: A retrospective single-c...
https://doi.org/10.1002/dc.24728
Diagnostic Cytopathology; Okano K, Ishida M et. al.

Feb 25th, 2021 - Olfactory neuroblastoma (ONB) is a rare malignant neuroectodermal tumor. Due to the rarity, there are scarce reports describing the cytological features of ONB. Thus, we aimed to analyze these cytological features and discuss their differences dep...

Prognostic significance of pretreatment 18F-FDG positron emission tomography/computed t...
https://doi.org/10.1007/s00247-021-05005-y 10.1016/S0140-6736(07)60983-0 10.1001/jama.2019.11642 10.1200/JCO.2008.16.6876 10.18632/oncotarget.7933 10.1200/JCO.2001.19.14.3397 10.2967/jnumed.108.060467 10.1016/j.ejrad.2015.09.027 10.1007/s13139-016-0451-8 10.2967/jnumed.110.083303 10.1097/RLU.0000000000001529
Pediatric Radiology; Sung AJ, Weiss BD et. al.

Feb 25th, 2021 - 18F-2-fluoro-2-deoxyglucose (FDG) positron emission tomography (PET) shows tumor activity in most neuroblastomas, but the role of 18F-FDG PET/CT in neuroblastoma remains to be defined. This study explored the prognostic significance of 18F-FDG PET...

see more →

Guidelines  7 results

Dr. Alice Yu, Pioneer in Immunotherapy for Neuroblastoma, to Receive Pediatric Oncology Award
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200152/full/

May 19th, 2020 - Alice Yu, MD, PhD, of the University of California San Diego School of Medicine, will receive the 2020 Pediatric Oncology Award. The award, first presented in 2002, recognizes a pediatric oncologist who has demonstrated outstanding leadership or a...

SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neu...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132052
Pediatric Blood & Cancer; Parikh NS, Howard SC et. al.

Mar 26th, 2015 - Neuroblastoma is the most common extracranial solid tumor in childhood in high-income countries (HIC), where consistent treatment approaches based on clinical and tumor biological risk stratification have steadily improved outcomes. However, in lo...

Guidelines for imaging and staging of neuroblastic tumors: consensus report from the In...
https://doi.org/10.1148/radiol.11101352
Radiology Brisse HJ, McCarville MB et. al.

May 18th, 2011 - Neuroblastoma is an enigmatic disease entity; some tumors disappear spontaneously without any therapy, while others progress with a fatal outcome despite the implementation of maximal modern therapy. However, strong prognostic factors can accurate...

Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marro...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696761
British Journal of Cancer; Beiske K, Burchill SA et. al.

Apr 29th, 2009 - Disseminating disease is a predictive and prognostic indicator of poor outcome in children with neuroblastoma. Its accurate and sensitive assessment can facilitate optimal treatment decisions. The International Neuroblastoma Risk Group (INRG) Task...

Neuroblastoma Treatment (PDQ®)–Health Professional Version
https://www.cancer.gov/types/neuroblastoma/hp/neuroblastoma-treatment-pdq?cid=eb_govdel

Neuroblastoma is the most common extracranial solid tumor in childhood. More than 650 cases are diagnosed each year in the United States.[4,5] The prevalence is about 1 case per 7,000 live births; the incidence is about 10.54 cases per 1 million p...

see more →

Drugs  79 results see all →

Clinicaltrials.gov  11,777 results

Activated ALK Cooperates with N-Myc via Wnt/β-catenin Signaling to Induce Neuroendocrin...
https://doi.org/10.1158/0008-5472.CAN-20-3351
Cancer Research; Unno K, Chalmers ZR et. al.

Feb 27th, 2021 - Neuroendocrine prostate cancer (NEPC) is an aggressive subtype of prostate cancer with poor prognosis, and there is a critical need for novel therapeutic approaches. NEPC is associated with molecular perturbation of several pathways including ampl...

Silencing of circular RNA circPDE5A suppresses neuroblastoma progression by targeting t...
https://doi.org/10.1080/00207454.2021.1896505
The International Journal of Neuroscience; Chen Y, Lin L et. al.

Feb 26th, 2021 - Objective: Neuroblastoma (NB) is the most common extra-cranial solid tumor in early childhood. Circular RNAs (circRNAs) have been implicated in the development of NB. The purpose of the current study was to explore the molecular action of circRNA ...

ZIF-8 nano confined protein-titanocene complex core-shell MOFs for efficient therapy of...
https://doi.org/10.1016/j.ijbiomac.2021.02.161
International Journal of Biological Macromolecules; Kulkarni S, Pandey A et. al.

Feb 26th, 2021 - In the present study, we have developed the core-shell metal organic framework (MOF) of zinc, wherein titanocene dichloride (TC) loaded lactoferrin (Lf) functioned as a core. The complexation of TC to Lf was studies using molecular dynamics study,...

Review of the cytological features of olfactory neuroblastoma: A retrospective single-c...
https://doi.org/10.1002/dc.24728
Diagnostic Cytopathology; Okano K, Ishida M et. al.

Feb 25th, 2021 - Olfactory neuroblastoma (ONB) is a rare malignant neuroectodermal tumor. Due to the rarity, there are scarce reports describing the cytological features of ONB. Thus, we aimed to analyze these cytological features and discuss their differences dep...

Prognostic significance of pretreatment 18F-FDG positron emission tomography/computed t...
https://doi.org/10.1007/s00247-021-05005-y 10.1016/S0140-6736(07)60983-0 10.1001/jama.2019.11642 10.1200/JCO.2008.16.6876 10.18632/oncotarget.7933 10.1200/JCO.2001.19.14.3397 10.2967/jnumed.108.060467 10.1016/j.ejrad.2015.09.027 10.1007/s13139-016-0451-8 10.2967/jnumed.110.083303 10.1097/RLU.0000000000001529
Pediatric Radiology; Sung AJ, Weiss BD et. al.

Feb 25th, 2021 - 18F-2-fluoro-2-deoxyglucose (FDG) positron emission tomography (PET) shows tumor activity in most neuroblastomas, but the role of 18F-FDG PET/CT in neuroblastoma remains to be defined. This study explored the prognostic significance of 18F-FDG PET...

see more →

News  133 results

Novel UK Developed Immunotherapy Shows Promise Against Neuroblastoma
https://www.medscape.com/viewarticle/941775

Nov 30th, 2020 - A novel chimeric antigen receptor (CAR) T-cell therapy developed by researchers at University College London (UCL) to target cancerous tumours has shown promising early results in children with neuroblastoma. In the UCL study, paediatric patients’...

New Drug Approved for Neuroblastoma Based on MSKCC Research
https://www.medscape.com/viewarticle/941675

Nov 25th, 2020 - The US Food and Drug Administration (FDA) has granted accelerated approval for a new drug for certain patients with neuroblastoma based on response rate results in small open-label trials. The drug is naxitamab (Danyelza, Y-mAbs Therapeutics), a h...

Dr. Alice Yu, Pioneer in Immunotherapy for Neuroblastoma, to Receive Pediatric Oncology Award
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200152/full/

May 19th, 2020 - Alice Yu, MD, PhD, of the University of California San Diego School of Medicine, will receive the 2020 Pediatric Oncology Award. The award, first presented in 2002, recognizes a pediatric oncologist who has demonstrated outstanding leadership or a...

Neuroblastoma: Osmosis Study Video
https://www.medscape.com/viewarticle/926532

Mar 26th, 2020 - Neuroblastoma is the most common extracranial solid cancer in childhood and the most common cancer in infancy. It is a neuroendocrine tumor, arising from any neural crest element of the sympathetic nervous system. It most frequently originates in ...

IVF With Frozen Embryos Linked With Higher Risk for Blastoma, Leukemia
https://www.staging.medscape.com/viewarticle/922436

Dec 11th, 2019 - (Reuters Health) - When frozen embryos are used during in vitro fertilization (IVF), the resulting children have a slightly higher risk for certain types of cancer, evidence from Denmark suggests. Analyzing health records of more than a million Da...

see more →

Patient Education  17 results see all →